
Izotropic Expands Marketing for Breast Cancer Imaging Technology
Vancouver, British Columbia and Sacramento, California–(Newsfile Corp. – June 13, 2025) – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic” or the “Company“), a medical device company commercializing imaging-based products utilizing innovative and emerging technologies for the more accurate screening, diagnoses, and treatment of breast cancers, announces that it has entered into an agreement…